Guidance on treatment for rare blood clots and low platelets related to COVID-19 vaccine apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
The insiduous impact of police violence on Black mental health
Opinion: Black Americans reported an increase in poor mental health days during weeks where more than one deadly racial incident was in the news A demonstrator reacts during a standoff with police along a perimeter fence during a protest decrying the shooting death of Daunte Wright, outside the Brooklyn Center Police Department, Wednesday, April 14, 2021, in Brooklyn Center, Minn. (AP Photo/John Minchillo)
The constant media coverage and real-time dissemination of footage on social media of unarmed African Americans harmed or killed by the police has left many Americans, especially Black and Brown folks, struggling to make sense of the violence.
Partnership supplies donated breast milk to NICU patients at Women & Infants pbn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pbn.com Daily Mail and Mail on Sunday newspapers.
Healthcentric Advisors to lead virtual COVID-19 learning collaborative for nursing homes
HEALTHCENTRIC ADVISORS, based in Providence, has been awarded a $600,000 federal contract to lead the Agency for Healthcare Research and Quality’s ECHO National Nursing Home COVID-19 Action Network. PROVIDENCE – Healthcentric Advisors, a Providence-based company specializing in health care improvement through data analysis and education, has been awarded a $600,000 federal contract to lead a COVID-19 learning collaborative for nursing homes. The company was selected by the Agency for Healthcare Research and Quality to launch the agency’s ECHO National Nursing Home COVID-19 Action…
Register to keep reading or subscribe today and receive unlimited access.
RESULTS OF clinical trial of a Alzheimer s disease treatment studied at Butler Hospital showed it could potentially be used to slow the symptoms of the disease. / COURTESY BUTLER HOSPITAL
PROVIDENCE – The results of clinical trials of an investigational drug to treat Alzheimer’s disease studied at Butler Hospital showed significant results in people with early symptomatic AD, Care New England Health System announced Monday.
The results, published in the New England Journal of Medicine, showed that the drug, donanemab, holds promise as a potential early treatment for Alzheimer’s. The drug was studied at Butler Hospital’s memory and aging program as part of the TRAILBLAZER-ALZ study, which was conducted at 61 research sites across the United States and Canada.